Yüklüyor......
Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy
Reslizumab, an anti-interleukin-5 monoclonal antibody, significantly reduces exacerbation frequency and improves lung function, asthma control and quality of life in adults with severe eosinophilic asthma, as demonstrated in Phase III studies. This secondary analysis assessed reslizumab's effic...
Kaydedildi:
| Yayımlandı: | ERJ Open Res |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
European Respiratory Society
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5570512/ https://ncbi.nlm.nih.gov/pubmed/28845430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00004-2017 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|